Virus Detection (Genome/Antigen) - Influenza A and B Viruses incl. Avian Influenza A Viruses (370)

Samples:

6 samples of 1.5 ml

Sample properties:

Lyophilised cell culture material or allantoic fluid

Additional Information:

For POCT systems: Please ensure that the sample matrix used in the EQA scheme is suitable for your test system. In case of uncertainty, we recommend contacting the manufacturer or supplier of your device. Note for laboratories from non-EU countries: The shipment of sample materials for participation in this EQA scheme is subject to a release by the Federal Office of Economic Affairs and Export Control according to the EU Dual-Use Regulation (VO (EU) 2021/821) for sample recipients in non-EU countries. INSTAND e.V. can only process EQA scheme orders from non-EU countries if the ordering laboratories provide a completed end-use certificate, company profile including contact details (e.g. excerpt from website) and, if applicable, an import permit! Failure to provide completed documents by the ordering deadline will unfortunately lead to the cancellation of your registration. Cooperation with: Nationales Referenzzentrum für Influenza, Robert Koch-Institut, Berlin; Friedrich-Loeffler-Institut, Bundesforschungsinstitut für Tiergesundheit, Nationales Referenzlabor für Aviäre Influenza, Insel Riems

Requirement for EQAS/PT according to Rili-BÄK

Parameters:

Option for typing of seasonal and avian influenza A viruses, Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for influenza A and B viruses and antigen testing

Certificate Validity: 12 months

Not subject to Rili-BÄK

Parameters:

not applicable

Certificate Validity: not applicable

Shipping Information:

Shipping not cooled

Safety Information:

Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.

EQAS/PT Experts: